TI
TGTX icon

Tidal Investments’s TG Therapeutics TGTX Stock Holding History

Tidal Investments’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.35M Buy
+24,590
New +$1.01M ﹤0.01% 1578
2026
Q1 		– Sell
-7,725
Closed -$230K – 2581
2025
Q4 		$230K Buy
+7,725
New +$252K ﹤0.01% 1950

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Tidal Investments's TGTX Position: Q2 2026 in Review

Tidal Investments opened a new position in TG Therapeutics (TGTX) in Q2 2026: 24,590 shares worth $1.35M. The stake represents ﹤0.01% of the portfolio and ranks #1578 among its holdings. This is a return to the name: Tidal Investments previously reported a position in TGTX as recently as Q4 2025.

Tidal Investments first reported a position in TGTX in Q4 2025 and has held it in 2 quarters since. 430 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Tidal Investments held 24,590 shares of TG Therapeutics worth $1.35M as of Q2 2026.
  • TG Therapeutics was a new Tidal Investments position in Q2 2026.
  • TG Therapeutics made up ﹤0.01% of Tidal Investments's portfolio in Q2 2026, its #1578 holding.
  • Tidal Investments first reported a position in TG Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 430 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.